trending Market Intelligence /marketintelligence/en/news-insights/trending/umLNHkBt47uBHQKoSG2aAw2 content esgSubNav
In This List

Kadmon sells MeiraGTx shares to raise $22M in net proceeds

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Kadmon sells MeiraGTx shares to raise $22M in net proceeds

New York-based biopharmaceutical company Kadmon Holdings Inc. divested some of its shareholding in MeiraGTx Holdings PLC.

The shareholder sold about 1.4 million MeiraGTx shares for $22 million in net proceeds to repay some of its debt and generate funds for corporate purposes. The company continues to hold 2.1 million shares of New York-based MeiraGTx, a gene therapy company developing treatments for various diseases including inherited blindness, different types of cancers and neurodegenerative diseases.